Dr. Roberts’ research interests primarily focus on the process and impact of genetic and biomarker-based risk assessment for adult-onset disorders. Since 2001, he has served as Co-Principal Investigator of the Risk Evaluation & Education for Alzheimer’s Disease (REVEAL) Study, an NIH-funded series of clinical trials assessing the psychological and behavioral impact of genetic risk disclosure for Alzheimer’s disease (AD). Now in its fifth trial, the REVEAL Study is examining the psychological and behavioral impact of disclosing amyloid neuroimaging results to individuals at risk of AD. In addition, Dr. Roberts has led numerous other federally-funded projects examining issues including the following: 1) the motivations, attitudes and behaviors of consumers receiving personal genomic services; 2) protocols for returning individual cancer and aortic disease genetic test results to research participants; and 3) communication challenges in disclosing germline and tumor sequencing results to patients with cancer and kidney disease. In addition to his work on disclosure of genetic results, Dr. Roberts also has interests in mental health and aging and is currently leading the adaptation of a community-based wellness program to improve mental well-being among older adults.